AbCellera Presents Data on Applications of T-Cell Engager Platform at SITC 2024
AbCellera Biologics Inc. - Common Shares (ABCL)
Company Research
Source: Business Wire
VANCOUVER, British Columbia--(BUSINESS WIRE)--AbCellera (Nasdaq: ABCL) today announced new data on its T-cell engager (TCE) platform, to be presented as a poster at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting at the George R. Brown Convention Center in Houston, Texas.AbCellera’s presentation, which is available for viewing here, describes:Strategies to address key challenges in TCE development:CD3-binding antibodies to widen the therapeutic window by generating TCEs with potent tumor-cell killing and optimal cytokine releaseMolecules to enhance efficacy for solid tumor indications by increasing T-cell activation and proliferation through costimulation of CD28 and 4-1BBApplication of the platform to two of AbCellera’s TCE programs:Preclinical characterization of TCEs against solid tumor targets B7-H4 and PSMA show tumor-cell killing and cytokine release profiles that are differentiated from clinical benchmarksAbout AbCellera’s T-Cell Engager PlatformCD3 T-cel
Show less
Read more
Impact Snapshot
Event Time:
ABCL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABCL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABCL alerts
High impacting AbCellera Biologics Inc. - Common Shares news events
Weekly update
A roundup of the hottest topics
ABCL
News
- Animal Health Partnering Terms and Agreements Analysis Report 2024: Access 269 Deals Signed by the World's Leading Life Science Companies Since 2017 [Yahoo! Finance]Yahoo! Finance
- AbCellera to Present at Upcoming Investor Conferences in December and January [Yahoo! Finance]Yahoo! Finance
- AbCellera to Present at Upcoming Investor Conferences in December and JanuaryBusiness Wire
- AbCellera Presents Data on Applications of T-Cell Engager Platform at SITC 2024 [Yahoo! Finance]Yahoo! Finance
- AbCellera Biologics Inc. (NASDAQ:ABCL) Just Reported And Analysts Have Been Cutting Their Estimates [Yahoo! Finance]Yahoo! Finance
ABCL
Earnings
- 11/4/24 - Miss
ABCL
Sec Filings
- 12/5/24 - Form 4
- 11/26/24 - Form 4
- 11/14/24 - Form SC
- ABCL's page on the SEC website